On Wishbone Day, May 6, 2021, Cameron Penn, President of the OIF Board of Directors, interviewed Dr. Brendan Lee, Principal Investigator for the Brittle Bone Disease Consortium (BBDC). Their discussion covered the history of the BBDC, current OI research, and answered audience questions.
This conversation is part of a series highlighting the work of the Brittle Bone Disorders Consortium (BBDC), a multi-center program that focuses on understanding and providing better treatment options for all types of osteogenesis imperfecta (OI). The BBDC is part of the National Institute of Health's (NIH) Rare Diseases Clinical Research Network (RDCRN) and contains sites around the US and Canada.
The learning objectives for all the BBDC Research Updates are to
-Highlight the work of the BBDC and individual research projects within it.
-Learn more about the process of OI research.